Invesco
EPZM

Invesco’s Epizyme, Inc EPZM Stock Holding History

Invesco’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,442
Closed -$63K – 4213
2022
Q1 		$63K Sell
54,442
-12,494
-19% -$20.4K ﹤0.01% 3908
2021
Q4 		$167K Sell
66,936
-5,020
-7% -$19.7K ﹤0.01% 3821
2021
Q3 		$368K Buy
71,956
+7,844
+12% +$47.6K ﹤0.01% 3567
2021
Q2 		$533K Buy
64,112
+11,536
+22% +$97.3K ﹤0.01% 3388
2021
Q1 		$458K Buy
52,576
+24,689
+89% +$255K ﹤0.01% 3376
2020
Q4 		$303K Buy
27,887
+13,710
+97% +$169K ﹤0.01% 3416
2020
Q3 		$169K Sell
14,177
-840,162
-98% -$11.3M ﹤0.01% 3498
2020
Q2 		$13.7M Buy
854,339
+214,662
+34% +$3.75M ﹤0.01% 1460
2020
Q1 		$9.92M Buy
639,677
+303,829
+90% +$6.53M ﹤0.01% 1528
2019
Q4 		$8.26M Buy
335,848
+319,355
+1,936% +$4.74M ﹤0.01% 1879
2019
Q3 		$170K Sell
16,493
-648
-4% -$8.17K ﹤0.01% 3574
2019
Q2 		$215K Sell
17,141
-600
-3% -$7.72K ﹤0.01% 3601
2019
Q1 		$220K Buy
+17,741
New +$198K ﹤0.01% 3601
2018
Q1 		– Sell
-62,710
Closed -$787K – 3790
2017
Q4 		$787K Sell
62,710
-342,803
-85% -$4.98M ﹤0.01% 3123
2017
Q3 		$7.72M Buy
405,513
+312,934
+338% +$4.77M ﹤0.01% 1720
2017
Q2 		$1.4M Buy
+92,579
New +$1.4M ﹤0.01% 2814
2015
Q3 		– Sell
-222
Closed -$5K – 4079
2015
Q2 		$5K Buy
+222
New +$4.27K ﹤0.01% 4239
2014
Q4 		– Sell
-8,230
Closed -$223K – 4114
2014
Q3 		$223K Buy
+8,230
New +$256K ﹤0.01% 3618

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco's EPZM Position: Q2 2022 in Review

Invesco sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 54,442 shares — an estimated $63K sold.

Invesco first reported a position in EPZM in Q3 2014 and held it in 18 quarters. The position peaked at $13.7M in Q2 2020. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Invesco reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 54,442 Epizyme, Inc shares in Q2 2022, an estimated $63K.
  • Invesco first reported a position in Epizyme, Inc in Q3 2014 and held it in 18 quarters.
  • Invesco's Epizyme, Inc position peaked at $13.7M in Q2 2020.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.